More articles from 1-Minute Consult
- What screening approach could improve early detection of ‘at-risk’ metabolic dysfunction–associated steatohepatitis in my patients?
Screening for MASH follows a stepwise, sequential approach, beginning with calculation of the fibrosis-4 index
- Should I prescribe statins for primary prevention of cardiovascular disease in older adults?
This decision should reflect the patient’s biological age and functional status rather than chronological age alone.
- Should potassium-competitive acid blockers replace proton pump inhibitors as first-line therapy for patients with severe (Los Angeles grade C or D) esophagitis?
Potassium-competitive acid blockers are reserved for patients who cannot tolerate proton pump inhibitors or who do not respond to them.
- Atrial fibrillation in patients with obesity: How can we optimize management?
Heart rate and rhythm control therapies often must be adjusted when treating patients with obesity, while other measures can reduce the onset or recurrence of atrial fibrillation.
- Should I consider low-dose rivaroxaban (2.5 mg) for my patient with peripheral artery disease?
For patients with high ischemic risk, rivaroxaban 2.5 mg twice daily with aspirin 81 or 100 mg daily is a proven strategy to reduce major cardiovascular and limb events.
- How should I incorporate emergency contraception counseling into my practice?
Emergency contraception counseling should be provided routinely to women at risk of unintended pregnancy as part of counseling on reproductive goals.
- How can I select the right thyroid hormone formulation for my patient with hypothyroidism?
Knowing the features of the available thyroid hormone formulations can provide a starting point for individualizing therapy for patients who have concerns about product formulations or remain symptomatic despite a normal thyroid-stimulating hormone level.
- Should we continue guideline-directed medical therapy in patients with heart failure with improved ejection fraction?
Therapy should be continued even if left ventricular ejection fraction improves, as normalization or improvement does not guarantee a permanent recovery.
- What is the optimal time for bone density screening in patients with premature ovarian insufficiency?
Dual-energy x-ray absorptiometry should be performed at diagnosis, with the timing of repeat scans predicated on the patient’s clinical risk factors for fracture.
- Do patients with severe community-acquired bacterial pneumonia benefit from systemic corticosteroids?
Recent evidence has swung the pendulum back in favor of using corticosteroids in patients with severe community-acquired pneumonia.